Business Description
Gilead Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US3755581036
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 1.43 | |||||
Debt-to-EBITDA | 6.1 | |||||
Interest Coverage | 6.64 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.86 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.3 | |||||
3-Year EBITDA Growth Rate | 36.6 | |||||
3-Year EPS without NRI Growth Rate | 24.5 | |||||
3-Year FCF Growth Rate | -0.3 | |||||
3-Year Book Growth Rate | 8.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 5.39 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.88 | |||||
9-Day RSI | 27.05 | |||||
14-Day RSI | 21.87 | |||||
6-1 Month Momentum % | -17.62 | |||||
12-1 Month Momentum % | -16.87 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.98 | |||||
Quick Ratio | 0.72 | |||||
Cash Ratio | 0.36 | |||||
Days Inventory | 110.03 | |||||
Days Sales Outstanding | 59.86 | |||||
Days Payable | 36.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.6 | |||||
Dividend Payout Ratio | 0.84 | |||||
3-Year Dividend Growth Rate | 3.3 | |||||
Forward Dividend Yield % | 4.7 | |||||
5-Year Yield-on-Cost % | 6.01 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 5.68 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.78 | |||||
Operating Margin % | 23.43 | |||||
Net Margin % | 1.76 | |||||
FCF Margin % | 29.13 | |||||
ROE % | 2.31 | |||||
ROA % | 0.79 | |||||
ROIC % | 5.1 | |||||
ROC (Joel Greenblatt) % | 37.48 | |||||
ROCE % | 4.18 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 182.08 | |||||
Forward PE Ratio | 17.24 | |||||
PE Ratio without NRI | 18.53 | |||||
Shiller PE Ratio | 10.74 | |||||
PEG Ratio | 3.5 | |||||
PS Ratio | 3 | |||||
PB Ratio | 4.68 | |||||
Price-to-Free-Cash-Flow | 10.27 | |||||
Price-to-Operating-Cash-Flow | 9.69 | |||||
EV-to-EBIT | 48.73 | |||||
EV-to-Forward-EBIT | 14 | |||||
EV-to-EBITDA | 24.29 | |||||
EV-to-Forward-EBITDA | 9.62 | |||||
EV-to-Revenue | 3.62 | |||||
EV-to-Forward-Revenue | 3.61 | |||||
EV-to-FCF | 12.42 | |||||
Price-to-Projected-FCF | 0.86 | |||||
Price-to-Median-PS-Value | 0.8 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.5 | |||||
Earnings Yield (Greenblatt) % | 2.05 | |||||
FCF Yield % | 9.79 | |||||
Forward Rate of Return (Yacktman) % | 17.67 |